Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)

Core Viewpoint - Cellectis S.A. (CLLS) is currently experiencing significant selling pressure, resulting in a 22.8% decline over the past four weeks, but analysts anticipate a potential turnaround due to oversold conditions and improved earnings expectations [8]. Technical Analysis - The Relative Strength Index (RSI) for CLLS is at 30, indicating that the stock is in oversold territory, which may suggest a potential price reversal [3][10]. - The RSI is a momentum oscillator that measures the speed and change of price movements, helping to identify overbought or oversold conditions [5][9]. Earnings Estimates - Over the last 30 days, the consensus EPS estimate for CLLS has increased by 41%, indicating a positive trend in earnings revisions that typically correlates with price appreciation [7]. - CLLS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 stocks ranked based on earnings estimate trends and EPS surprises, further supporting the potential for a turnaround [5].